Stifel Financial’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.1M | Sell |
35,765
-2,597
| -7% | -$1.67M | 0.02% | 637 |
|
|
2025
Q4 | $26M | Buy |
38,362
+1,337
| +4% | +$911K | 0.02% | 543 |
|
|
2025
Q3 | $23.7M | Buy |
37,025
+1,621
| +5% | +$984K | 0.02% | 563 |
|
|
2025
Q2 | $19M | Buy |
35,404
+1,856
| +6% | +$888K | 0.02% | 616 |
|
|
2025
Q1 | $14.1M | Buy |
33,548
+6,825
| +26% | +$2.96M | 0.02% | 709 |
|
|
2024
Q4 | $11M | Sell |
26,723
-6,893
| -21% | -$3.02M | 0.01% | 811 |
|
|
2024
Q3 | $17M | Sell |
33,616
-5,996
| -15% | -$2.91M | 0.02% | 642 |
|
|
2024
Q2 | $19.3M | Buy |
39,612
+4,495
| +13% | +$2.26M | 0.02% | 561 |
|
|
2024
Q1 | $19M | Sell |
35,117
-358
| -1% | -$196K | 0.02% | 572 |
|
|
2023
Q4 | $19.7M | Buy |
35,475
+3,871
| +12% | +$1.82M | 0.02% | 517 |
|
|
2023
Q3 | $13.8M | Buy |
31,604
+5,789
| +22% | +$2.89M | 0.02% | 602 |
|
|
2023
Q2 | $13M | Sell |
25,815
-4,638
| -15% | -$2.22M | 0.02% | 620 |
|
|
2023
Q1 | $15.2M | Buy |
30,453
+1,079
| +4% | +$516K | 0.02% | 540 |
|
|
2022
Q4 | $12M | Sell |
29,374
-47
| -0.2% | -$18.2K | 0.02% | 602 |
|
|
2022
Q3 | $9.59M | Sell |
29,421
-3,408
| -10% | -$1.25M | 0.02% | 646 |
|
|
2022
Q2 | $11.5M | Sell |
32,829
-27,577
| -46% | -$11.2M | 0.02% | 608 |
|
|
2022
Q1 | $33M | Sell |
60,406
-2,358
| -4% | -$1.24M | 0.05% | 345 |
|
|
2021
Q4 | $41.3M | Sell |
62,764
-700
| -1% | -$439K | 0.05% | 292 |
|
|
2021
Q3 | $39.5M | Buy |
63,464
+369
| +0.6% | +$248K | 0.06% | 282 |
|
|
2021
Q2 | $39.8M | Buy |
63,095
+2,007
| +3% | +$1.11M | 0.06% | 280 |
|
|
2021
Q1 | $29.9M | Sell |
61,088
-6,852
| -10% | -$3.43M | 0.05% | 316 |
|
|
2020
Q4 | $34M | Buy |
67,940
+1,757
| +3% | +$786K | 0.06% | 282 |
|
|
2020
Q3 | $26M | Buy |
66,183
+5,438
| +9% | +$2.01M | 0.05% | 298 |
|
|
2020
Q2 | $20.1M | Buy |
60,745
+6,794
| +13% | +$1.97M | 0.05% | 325 |
|
|
2020
Q1 | $13.1M | Buy |
53,951
+3,943
| +8% | +$1.03M | 0.04% | 372 |
|
|
2019
Q4 | $13.1M | Buy |
50,008
+34,391
| +220% | +$9.06M | 0.03% | 500 |
|
|
2019
Q3 | $4.25M | Buy |
15,617
+69
| +0.4% | +$19.2K | 0.01% | 898 |
|
|
2019
Q2 | $4.28M | Sell |
15,548
-1,742
| -10% | -$429K | 0.01% | 919 |
|
|
2019
Q1 | $3.87M | Buy |
17,290
+2,667
| +18% | +$551K | 0.01% | 927 |
|
|
2018
Q4 | $2.72M | Sell |
14,623
-2,889
| -16% | -$592K | 0.01% | 1012 |
|
|
2018
Q3 | $4.35M | Buy |
17,512
+1,115
| +7% | +$271K | 0.01% | 895 |
|
|
2018
Q2 | $3.58M | Sell |
16,397
-1,192
| -7% | -$246K | 0.01% | 947 |
|
|
2018
Q1 | $3.36M | Sell |
17,589
-1,813
| -9% | -$335K | 0.01% | 948 |
|
|
2017
Q4 | $3.04M | Sell |
19,402
-482
| -2% | -$75.9K | 0.01% | 969 |
|
|
2017
Q3 | $3.1M | Sell |
19,884
-4,239
| -18% | -$670K | 0.01% | 933 |
|
|
2017
Q2 | $3.89M | Sell |
24,123
-1,072
| -4% | -$174K | 0.01% | 813 |
|
|
2017
Q1 | $3.9M | Buy |
25,195
+3,611
| +17% | +$498K | 0.02% | 807 |
|
|
2016
Q4 | $2.53M | Buy |
21,584
+1,618
| +8% | +$185K | 0.01% | 936 |
|
|
2016
Q3 | $2.24M | Buy |
19,966
+146
| +0.7% | +$15.4K | 0.01% | 942 |
|
|
2016
Q2 | $1.84M | Buy |
19,820
+917
| +5% | +$78.7K | 0.01% | 1038 |
|
|
2016
Q1 | $1.48M | Sell |
18,903
-1,158
| -6% | -$83.4K | 0.01% | 1057 |
|
|
2015
Q4 | $1.46M | Buy |
20,061
+730
| +4% | +$52.1K | 0.01% | 1114 |
|
|
2015
Q3 | $1.44M | Buy |
19,331
+5,231
| +37% | +$375K | 0.01% | 1063 |
|
|
2015
Q2 | $901K | Buy |
14,100
+3,564
| +34% | +$247K | ﹤0.01% | 1392 |
|
|
2015
Q1 | $814K | Buy |
10,536
+4,042
| +62% | +$315K | ﹤0.01% | 1377 |
|
|
2014
Q4 | $482K | Buy |
6,494
+576
| +10% | +$40.4K | ﹤0.01% | 1627 |
|
|
2014
Q3 | $349K | Buy |
5,918
+710
| +14% | +$44.9K | ﹤0.01% | 1722 |
|
|
2014
Q2 | $348K | Sell |
5,208
-94
| -2% | -$5.98K | ﹤0.01% | 1698 |
|
|
2014
Q1 | $322K | Buy |
+5,302
| New | +$316K | ﹤0.01% | 1675 |
|
Other funds holding IDXX
VCM
VPM
Stifel Financial's IDXX Position: Q1 2026 in Review
Stifel Financial reduced its Idexx Laboratories (IDXX) stake by 6.8% in Q1 2026, selling an estimated $1.67M and leaving 35,765 shares worth $20.1M. The position accounts for 0.02% of the portfolio, ranked #637.
Stifel Financial first reported a position in IDXX in Q1 2014 and has held it in 49 quarters since. The position peaked at $41.3M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Stifel Financial held 35,765 shares of Idexx Laboratories worth $20.1M as of Q1 2026.
- Stifel Financial sold 2,597 Idexx Laboratories shares in Q1 2026, an estimated $1.67M.
- Idexx Laboratories made up 0.02% of Stifel Financial's portfolio in Q1 2026, its #637 holding.
- Stifel Financial first reported a position in Idexx Laboratories in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Idexx Laboratories position peaked at $41.3M in Q4 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.